These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29644867)

  • 1. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
    Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
    Awad NS; Paul V; Al-Sayah MH; Husseini GA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):705-714. PubMed ID: 30873869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound.
    Ben Daya SM; Paul V; Awad NS; Al Sawaftah NM; Al Sayah MH; Husseini GA
    J Biomed Nanotechnol; 2021 Jan; 17(1):90-99. PubMed ID: 33653499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
    Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
    Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer.
    Ninomiya K; Yamashita T; Kawabata S; Shimizu N
    Ultrason Sonochem; 2014 Jul; 21(4):1482-8. PubMed ID: 24418100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.
    Jain AS; Goel PN; Shah SM; Dhawan VV; Nikam Y; Gude RP; Nagarsenker MS
    Biomed Pharmacother; 2014 May; 68(4):429-38. PubMed ID: 24721327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
    Kurmi BD; Paliwal R; Paliwal SR
    Int J Biol Macromol; 2020 Dec; 164():2881-2894. PubMed ID: 32853621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-triggered herceptin liposomes for breast cancer therapy.
    Elamir A; Ajith S; Sawaftah NA; Abuwatfa W; Mukhopadhyay D; Paul V; Al-Sayah MH; Awad N; Husseini GA
    Sci Rep; 2021 Apr; 11(1):7545. PubMed ID: 33824356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of doxorubicin via estrone-appended liposomes.
    Rai S; Paliwal R; Vaidya B; Khatri K; Goyal AK; Gupta PN; Vyas SP
    J Drug Target; 2008 Jul; 16(6):455-63. PubMed ID: 18604658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Targeted Estrone Liposomes Using a Herringbone Micromixer.
    Agam M; Paul V; Abdelgawad M; Husseini GA
    IEEE Trans Nanobioscience; 2024 Jul; 23(3):472-481. PubMed ID: 38530728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.
    Battistini L; Burreddu P; Sartori A; Arosio D; Manzoni L; Paduano L; D'Errico G; Sala R; Reia L; Bonomini S; Rassu G; Zanardi F
    Mol Pharm; 2014 Jul; 11(7):2280-93. PubMed ID: 24819754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.
    Kim MW; Niidome T; Lee R
    Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31614820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further Evolution of Multifunctional Niosomes Based on Pluronic Surfactant: Dual Active Targeting and Drug Combination Properties.
    Tavano L; Mauro L; Naimo GD; Bruno L; Picci N; Andò S; Muzzalupo R
    Langmuir; 2016 Sep; 32(35):8926-33. PubMed ID: 27504856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells.
    Shen Q; Qiu L
    J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.